How Well Are We Applying Quantitative Methods to Reverse Translation to Inform Early Clinical Development?

E-ISSN： 1532-6535|103|2|174-176

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.103, Iss.2, 2018-02, pp. : 174-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bedside to Bench: Integrating Quantitative Clinical Pharmacology and Reverse Translation to Optimize Drug Development

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 196-198

John Wiley & Sons Inc

Access to resources Recommend Favorite

Personalized medicine in bipolar disorder: how can we overcome the barriers to clinical translation?

By Squassina Alessio Pisanu Claudia

Personalized Medicine, Vol. 10, Iss. 8, 2013-11 ,pp. : 765-768

Future Medicine

Access to resources Recommend Favorite

Model‐Informed Reverse and Forward Translation of Safety Risks in Drug Development

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 199-201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical application of quantitative methods in the study of spasticity

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 9-9236, Iss. 6part2, 1964-11 ,pp. : 918-941

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient‐Centered Reverse Translation

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 168-170

John Wiley & Sons Inc

Access to resources Recommend Favorite